In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28435302)

Published in Infect Drug Resist on April 10, 2017

Authors

Larissa S Freitas1, Núbia Caroline C Almeida1, Maria Alice Freitas Queiroz1, Marcelo M Zaninotto2, Hellen T Fuzii3, Alfredo Ribeiro-Silva4, Antonio Cr Vallinoto1, Marluísa Og Ishak1, Juarez As Quaresma3, Ricardo Ishak1

Author Affiliations

1: Virus Laboratory, Institute of Biological Sciences, Federal University of Para.
2: Hospital of Clinic Gaspar Viana.
3: Laboratory of Immunopathology, Nucleus of Tropical Medicine, Federal University of Para, Belém.
4: Departament of Pathology, Medical School of Ribeirão Preto, University of Sao Paulo, São Paulo, Brazil.

Articles cited by this

Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41

Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest (1987) 7.95

Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med (2007) 4.47

Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98

Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest (1991) 2.76

Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res (2007) 2.43

Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28

Gender differences in coronary heart disease. Neth Heart J (2010) 2.16

Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15

Recent infection as a risk factor for cerebrovascular ischemia. Stroke (1995) 2.11

Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol (1987) 1.79

Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol (1991) 1.76

Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev (2005) 1.60

Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis (2010) 1.41

The checkerboard tissue block. An improved multitissue control block. Lab Invest (1990) 1.36

Cellular senescence, vascular disease, and aging: Part 1 of a 2-part review. Circulation (2011) 1.17

Regional localization of the interferon-beta 2/B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21. Genomics (1988) 1.17

Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun (1996) 1.17

Infection and inflammation as risk factors for myocardial infarction. Eur Heart J (1993) 1.10

Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol (2000) 1.05

Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis (1998) 1.04

Infectious causes of atherosclerosis. Am Heart J (1999) 0.98

Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice. Infect Immun (2000) 0.93

Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda. PLoS One (2012) 0.88

Impact of socio-economic profile on the prosthesis type choice used on heart surgery. Rev Bras Cir Cardiovasc (2012) 0.83

Footprints of atherosclerotic coronary heart disease in children. Rev Port Cardiol (2004) 0.80

Assessing coronary heart disease in women. Maturitas (2009) 0.78

Chlamydia pneumoniae: inflammation and instability of the atherosclerotic plaque. Atherosclerosis (1998) 0.77